English
简体中文
Total: £ 56.28
Published Date: 2024-04-08 | Pages: 78 | Tables: 178 | Pharma & Healthcare
The global Diphtheria, Tetanus, and Pertussis Combined Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diphtheria, Tetanus, and Pertussis Combined Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diphtheria, Tetanus, and Pertussis Combined Vaccine.
Report Scope
The Diphtheria, Tetanus, and Pertussis Combined Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Million Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diphtheria, Tetanus, and Pertussis Combined Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segment by Type
Inactivated Vaccine
Other
Segment by Application
12 Months Below
12 Months Above
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diphtheria, Tetanus, and Pertussis Combined Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diphtheria, Tetanus, and Pertussis Combined Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Overview
1.1 Product Overview and Scope of Diphtheria, Tetanus, and Pertussis Combined Vaccine
1.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Segment by Type
1.2.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Inactivated Vaccine
1.2.3 Other
1.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Segment by Application
1.3.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Value by Application: (2024-2030)
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size Estimates and Forecasts
1.4.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue 2019-2030
1.4.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales 2019-2030
1.4.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Competition by Manufacturers
2.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diphtheria, Tetanus, and Pertussis Combined Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diphtheria, Tetanus, and Pertussis Combined Vaccine, Product Type & Application
2.7 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Competitive Situation and Trends
2.7.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diphtheria, Tetanus, and Pertussis Combined Vaccine Players Market Share by Revenue
2.7.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Retrospective Market Scenario by Region
3.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Region: 2019-2030
3.2.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Region: 2019-2024
3.2.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Region: 2025-2030
3.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region: 2019-2030
3.3.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region: 2019-2024
3.3.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region: 2025-2030
3.4 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Facts & Figures by Country
3.4.1 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2019-2030)
3.4.3 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Facts & Figures by Country
3.5.1 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2019-2030)
3.5.3 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Facts & Figures by Country
3.7.1 Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Type (2019-2030)
4.1.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Type (2019-2024)
4.1.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Type (2025-2030)
4.1.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Type (2019-2030)
4.2.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Type (2019-2024)
4.2.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Type (2025-2030)
4.2.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Application (2019-2030)
5.1.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Application (2019-2024)
5.1.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Application (2025-2030)
5.1.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Application (2019-2030)
5.2.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Application (2019-2024)
5.2.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Application (2025-2030)
5.2.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Corporation Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 KM Biologics
6.4.1 KM Biologics Corporation Information
6.4.2 KM Biologics Description and Business Overview
6.4.3 KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Portfolio
6.4.5 KM Biologics Recent Developments/Updates
6.5 Wuhan Institute of Biological Products
6.5.1 Wuhan Institute of Biological Products Corporation Information
6.5.2 Wuhan Institute of Biological Products Description and Business Overview
6.5.3 Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Corporation Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Chengdu Institute of Biological Products
6.6.1 Chengdu Institute of Biological Products Corporation Information
6.6.2 Chengdu Institute of Biological Products Description and Business Overview
6.6.3 Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Portfolio
6.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.8 Minhai Biotechnology
6.8.1 Minhai Biotechnology Corporation Information
6.8.2 Minhai Biotechnology Description and Business Overview
6.8.3 Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product Portfolio
6.8.5 Minhai Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Industry Chain Analysis
7.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Mode & Process
7.4 Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales and Marketing
7.4.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Channels
7.4.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Distributors
7.5 Diphtheria, Tetanus, and Pertussis Combined Vaccine Customers
8 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Dynamics
8.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Industry Trends
8.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Drivers
8.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Challenges
8.4 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses) of Key Manufacturers (2019-2024)
Table 5. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Diphtheria, Tetanus, and Pertussis Combined Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Diphtheria, Tetanus, and Pertussis Combined Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Diphtheria, Tetanus, and Pertussis Combined Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Diphtheria, Tetanus, and Pertussis Combined Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diphtheria, Tetanus, and Pertussis Combined Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Region (2019-2024) & (Million Doses)
Table 18. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Region (2025-2030) & (Million Doses)
Table 20. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2019-2024) & (Million Doses)
Table 27. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2025-2030) & (Million Doses)
Table 28. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2019-2024) & (Million Doses)
Table 32. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2025-2030) & (Million Doses)
Table 33. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Region (2019-2024) & (Million Doses)
Table 37. Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Region (2025-2030) & (Million Doses)
Table 38. Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2019-2024) & (Million Doses)
Table 42. Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2025-2030) & (Million Doses)
Table 43. Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2019-2024) & (Million Doses)
Table 47. Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2025-2030) & (Million Doses)
Table 48. Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses) by Type (2019-2024)
Table 51. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses) by Type (2025-2030)
Table 52. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price (USD/Dose) by Type (2019-2024)
Table 59. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price (USD/Dose) by Type (2025-2030)
Table 60. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses) by Application (2019-2024)
Table 61. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses) by Application (2025-2030)
Table 62. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price (USD/Dose) by Application (2019-2024)
Table 69. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price (USD/Dose) by Application (2025-2030)
Table 70. Sanofi Pasteur Corporation Information
Table 71. Sanofi Pasteur Description and Business Overview
Table 72. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 74. Sanofi Pasteur Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Mitsubishi Tanabe Pharma Corporation Information
Table 81. Mitsubishi Tanabe Pharma Description and Business Overview
Table 82. Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 84. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 85. KM Biologics Corporation Information
Table 86. KM Biologics Description and Business Overview
Table 87. KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 89. KM Biologics Recent Developments/Updates
Table 90. Wuhan Institute of Biological Products Corporation Information
Table 91. Wuhan Institute of Biological Products Description and Business Overview
Table 92. Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 94. Wuhan Institute of Biological Products Recent Developments/Updates
Table 95. Walvax Biotechnology Corporation Information
Table 96. Walvax Biotechnology Description and Business Overview
Table 97. Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 99. Walvax Biotechnology Recent Developments/Updates
Table 100. Chengdu Institute of Biological Products Corporation Information
Table 101. Chengdu Institute of Biological Products Description and Business Overview
Table 102. Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 104. Chengdu Institute of Biological Products Recent Developments/Updates
Table 105. Minhai Biotechnology Corporation Information
Table 106. Minhai Biotechnology Description and Business Overview
Table 107. Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 109. Minhai Biotechnology Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Diphtheria, Tetanus, and Pertussis Combined Vaccine Distributors List
Table 113. Diphtheria, Tetanus, and Pertussis Combined Vaccine Customers List
Table 114. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Trends
Table 115. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Drivers
Table 116. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Challenges
Table 117. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Diphtheria, Tetanus, and Pertussis Combined Vaccine
Figure 2. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Share by Type in 2023 & 2030
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Other Product Picture
Figure 6. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Share by Application in 2023 & 2030
Figure 8. 12 Months Below
Figure 9. 12 Months Above
Figure 10. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (2019-2030) & (Million Doses)
Figure 13. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price (USD/Dose) & (2019-2030)
Figure 14. Diphtheria, Tetanus, and Pertussis Combined Vaccine Report Years Considered
Figure 15. Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Diphtheria, Tetanus, and Pertussis Combined Vaccine Players: Market Share by Revenue in 2023
Figure 18. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Country (2019-2030)
Figure 41. Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Country (2019-2030)
Figure 42. Mexico Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Country (2019-2030)
Figure 47. Turkey Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. UAE Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Global Sales Market Share of Diphtheria, Tetanus, and Pertussis Combined Vaccine by Type (2019-2030)
Figure 51. Global Revenue Market Share of Diphtheria, Tetanus, and Pertussis Combined Vaccine by Type (2019-2030)
Figure 52. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price (USD/Dose) by Type (2019-2030)
Figure 53. Global Sales Market Share of Diphtheria, Tetanus, and Pertussis Combined Vaccine by Application (2019-2030)
Figure 54. Global Revenue Market Share of Diphtheria, Tetanus, and Pertussis Combined Vaccine by Application (2019-2030)
Figure 55. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price (USD/Dose) by Application (2019-2030)
Figure 56. Diphtheria, Tetanus, and Pertussis Combined Vaccine Value Chain
Figure 57. Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
